Renal Disease Treatments: Products and Therapies
Report Highlights
- Overall sales in the global market for renal failure treatmentwere worth nearly $28 billion in 2009, it is estimated to increase to $33.5 billion at a 5 year compound annual growth rate (CAGR) of 3.7%.
- The largest segment CKD treatment products and therapies (including dialysis consumables) market was nearly $26.5 billion in 2009. This is expected to rise to $31.7 billion in 2014, at a CAGR of 3.6%.
- ARF treatment products and therapies (including dialysis consumables) market reached $955 million in 2009 and is projected to reach $1.4 billion in 2014, at a CAGR of 8.7%.
INTRODUCTION
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to any of BCC’s many industry newsletters
- Read announcements of recently published reports and newly launched newsletters
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.